Free Trial
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

ZIVO Bioscience logo
$11.99 0.00 (0.00%)
As of 07/3/2025

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

Key Stats

Today's Range
$11.99
$11.99
50-Day Range
$11.99
$18.80
52-Week Range
$5.80
$22.15
Volume
2 shs
Average Volume
997 shs
Market Capitalization
$45.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

ZIVO Stock Analysis - Frequently Asked Questions

ZIVO Bioscience's stock was trading at $21.50 at the start of the year. Since then, ZIVO stock has decreased by 44.2% and is now trading at $11.99.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) posted its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.06) earnings per share for the quarter. The biotechnology company had revenue of $0.02 million for the quarter.

Shares of ZIVO Bioscience reverse split before market open on Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include Canopy Growth (CGC), Meta Platforms (META), OPKO Health (OPK), Johnson & Johnson (JNJ), ACADIA Pharmaceuticals (ACAD), Aravive (ARAV) and Alibaba Group (BABA).

Company Calendar

Last Earnings
5/11/2020
Today
7/04/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.78 million
Pretax Margin
-17,113.75%

Debt

Sales & Book Value

Annual Sales
$15.85 thousand
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-14.80

Miscellaneous

Free Float
2,911,000
Market Cap
$45.72 million
Optionable
Not Optionable
Beta
0.02

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ZIVO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners